Minimum infective dose of severe acute respiratory syndrome coronavirus 2 based on the current evidence: A systematic review

OBJECTIVE: Understanding the minimum infective dose is significant for risk assessment in the performance of suitable infection control strategies in healthcare centers. However, the literature lacks strong evidence regarding this value for severe acute respiratory syndrome coronavirus 2. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: SeyedAlinaghi, SeyedAhmad, Karimi, Amirali, Mojdeganlou, Hengameh, Pashaei, Zahra, Mirzapour, Pegah, Shamsabadi, Ahmadreza, Barzegary, Alireza, Afroughi, Fatemeh, Dehghani, Soheil, Janfaza, Nazanin, Fakhfouri, Amirata, Khodaei, Sepideh, Mehraeen, Esmaeil, Dadras, Omid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379270/
https://www.ncbi.nlm.nih.gov/pubmed/35983085
http://dx.doi.org/10.1177/20503121221115053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379270/
https://www.ncbi.nlm.nih.gov/pubmed/35983085
http://dx.doi.org/10.1177/20503121221115053

Ejemplares similares